ratios (HRs) were calculated using Cox proportional hazards regression models. Results During a median follow-up of 4.1 years, we documented 270 incident T2D cases. After multivariate adjustment, total dairy product consumption was inversely associated with T2D risk [0.68 (95 % CI 0.47-0.98); P-trend = .040]. This association appeared to be mainly attributed to low-fat dairy; the multivariate HRs (95 % CIs) comparing the highest versus the lowest tertile consumption were 0.65 (0.45-0.94) for low-fat dairy products and 0.67 (0.46-0.95) for low-fat milk (both P-trend <.05). Total yogurt consumption was associated with a lower T2D risk ; P-trend = .002]. An increased consumption of total low-fat dairy and total yogurt during the follow-up was inversely associated with T2D; HRs were
Introduction
Type 2 diabetes (T2D) incidence is increasing at an alarming rate worldwide and, especially in elderly population [1] . Compelling evidence shows that dietary and lifestyle changes are a key element in the prevention of T2D and obesity-associated metabolic disturbances [2, 3] . Of the many food groups that may offer protection against T2D, dairy products are one of the most frequently investigated. Largely owing to their saturated fat content, dairy products are conventionally perceived as having an adverse impact on health [4] . However, they are nutrient-dense food and contain high-quality protein, vitamins (A, D, B 2 , B 12 , and menaquinones), and minerals (calcium, magnesium, and potassium), which have been shown to have beneficial effects on T2D risk [5] .
Limited evidence suggests that insulin sensitivity can be improved when dairy consumption is promoted [6, 7] . In addition, four meta-analyses of prospective studies have recently reported an overall reduced risk of T2D incidence in subjects with higher dairy consumption, particularly the low-fat variety [8] [9] [10] [11] . Nonetheless, the results of studies from these meta-analyses have shown mixed results: Some have reported inverse associations for low-fat dairy [12] [13] [14] [15] [16] , milk [17, 18] , low-fat or skim milk [12, 13, 19] , cheese [13] , and yogurt [12, 13, 16] , whereas other failed to find associations between dairy subtype consumption and T2D [20] [21] [22] [23] [24] [25] [26] . The largest studies in all these meta-analyses were from the USA [12] [13] [14] [15] 21] and Asia [22] , and European studies have provided limited evidence on this issue [26, 27] . Recent studies conducted on European population that have focused on specific dairy subtypes and T2D risk have found inconsistent results. In two large prospective studies using data from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts [EPICInterAct study [27] including eight European countries and the EPIC-Norfolk study [28] including a UK populationbased cohort)], only the consumption of fermented dairy, specifically yogurt and low-fat unripened cheese, was associated with decreased risks of incident T2D. Nevertheless, consumption of total and whole-fat dairy, milk, cheese, and whole-fat fermented dairy was not associated with T2D [27, 28] . Conversely, in the EPIC-Potsdam study [26] and two other prospective studies conducted in English and Danish populations [23, 24] , no association between dairy and T2D was found.
The aforementioned studies were conducted in apparently healthy young or middle-aged individuals. However, to our knowledge, no study has examined the association between dairy consumption and T2D risk in elderly individuals at high cardiovascular risk. Therefore, we aimed not only to prospectively explore the associations between total consumption of dairy and specific dairy subgroups and the T2D risk but also to estimate substitution effects of alternative foods for dairy products on T2D risk in an elderly Mediterranean population at high cardiovascular risk in the frame of the PREDIMED study.
Materials and methods

Study design and participants
The present study was conducted with data from nondiabetic participants at high risk of coronary heart disease (CHD) from the PREvención con DIeta MEDiterránea (PREDIMED) study. The PREDIMED study is a large, parallel group, randomized, multicenter, and controlled trial designed to assess the effect of the Mediterranean diet on the primary prevention of cardiovascular disease (CVD) (http://www.predimed.es). Recruitment took place between October 2003 and January 2009, and 7,447 participants were randomly assigned to three intervention groups: two Mediterranean diet groups (supplemented with either virgin olive oil or nuts) and a control low-fat diet group. The design of the PREDIMED trial has been reported in detail elsewhere [29] . The study was conducted in agreement with the Declaration of Helsinki. The Institutional Review Board of the recruitment centers approved the study protocol, and participants gave their informed consent.
The participants were eligible if they were men aged 55-80 years and women aged 60-80 years, who were free of CVD at baseline and fulfilled at least one of the two following criteria: presence of T2D and/or three or more cardiovascular risk factors, including family history of early onset CHD, smoking, hypertension, dyslipidemia, or overweight.
In the present study, we analyzed data as in an observational prospective cohort, and only participants without diagnoses of T2D at baseline were included (n = 3,833). Individuals who lacked measures of glucose control, who did not have information on the baseline FFQ, or implausible daily energy intake (<500 or >3,500 kcal/ day for women and <800 or >4,000 kcal/day for men; n = 379) were excluded. The final analyses included 3,454 individuals.
Ascertainment of incident T2D
T2D was a prespecified secondary outcome of the PRED-IMED trial. It was considered to be present at baseline by clinical diagnosis or use of antidiabetic medication. Incident (new onset) cases of T2D during the followup were diagnosed using the American Diabetes Association criteria, namely fasting plasma glucose ≥126 mg/ dL (7 mmol/L) or 2-h plasma glucose ≥200 mg/dL (11.1 mmol/L) after a 75-g oral glucose load. All participants' medical records were reviewed yearly in each center by physicians-investigators. When cases of new onset T2D were identified on the basis of a medical diagnosis reported in the medical charts or a glucose test during routine biochemical analyses, these reports and all medical documentation of the participant were sent to the PREDIMED Clinical Events Committee, whose members were blinded to treatment allocation. Only when a second test had been done using the same criteria within the following 3 months, the new case of T2D confirmed was the end point definitively confirmed by the adjudication committee. Only T2D events that were confirmed between 1 October 2003 and 1 December 2010 were included in the analyses.
Assessment of dairy consumption
At baseline and yearly during follow-up, diet was assessed using a 137-item semi-quantitative food frequency questionnaire (FFQ) validated for the PREDIMED study [29] . Energy and nutrient intake were calculated from Spanish food composition tables [29] . With regard to dairy product, in the validation study, the intra-class correlation coefficient between dairy product consumption from the FFQ and repeated food records was 0.84.
Responses to individual dairy items of the FFQ were converted to average daily consumptions (g/day) and then combined and categorized into total dairy (including all types of milk, yogurt and cheeses, custard, whipped cream, butter, and ice cream), low-fat dairy (semi-skim/skim milk and skim yogurt), and whole-fat dairy (whole-fat milk and whole-fat yogurt). Dairy consumption was also categorized by subtype into the consumption of milk (total, low-fat, and whole-fat milk), yogurt (total, low-fat and whole-fat yogurt), cheese (petit Suisse, ricotta, cottage, spreadable, and semi-cured/cured cheeses), fermented dairy (all types of yogurt and cheeses), concentrated full fat dairy (butter, whipped cream, and all types of cheeses), and processed dairy (condensed milk, milkshakes, ice cream, and custard). The dairy consumption at baseline and in every follow-up assessment was adjusted for total energy intake using the residuals method.
Assessment of covariates
At baseline and yearly, all participants completed: (a) a 47-item questionnaire about education, lifestyle, history of illnesses, and medication use; and (b) a validated Spanish version of the Minnesota Leisure-Time Physical Activity Questionnaire [29] . In addition, anthropometric variables and blood pressure were determined by trained staff. Blood samples were also collected from all participants after an overnight fast. Plasma fasting glucose and serum levels of total cholesterol, HDL-cholesterol, and triglycerides were measured by routine laboratory tests using standard enzymatic methods.
Statistical analysis
Person time of follow-up was calculated as the interval between the randomization date and the earliest date of the follow-up contact at which a new diagnosis of T2D was ascertained, death from any cause, or date of the last contact visit, whichever came first. To better represent the long-term consumption of dairy products and to minimize within person variation, we used the cumulative average of energy-adjusted dairy consumption for all analyses based on assessments from items of all FFQs administered at baseline and yearly during the follow-up. Given that after developing T2D, participants may alter their dietary pattern; we only used data from all the available FFQs until a year before the last date of T2D diagnoses was ascertained. Participants were categorized into dairy consumption tertiles. Two upper tertiles were compared with the lowest tertile (reference). Multivariate time-dependent Cox proportional hazard regression models were fitted to estimate the hazard ratios (HRs) and 95 % CIs of T2D for dairy consumption. Model 1 was adjusted for baseline age, sex, and BMI. Model 2 was additionally adjusted for intervention group, baseline smoking status, physical activity, educational level, hypertension or antihypertensive drug use, fasting glucose, HDL-cholesterol, and triglycerides concentrations. To minimize the confounding by other dietary factors, a third model (model 3) was additionally adjusted for the cumulative average consumption of vegetables, legumes, fruits, meat, fish, olive oil and nuts (all in energy-adjusted quintiles), and alcohol.
We conducted subsequent multivariate analyses to examine the HRs for T2D of substituting one serving/day of alternative foods for one serving/day of dairy products (only those dairy products that were associated with T2D). These dietary variables were included as continuous variables in the same multivariate model (model 2). The differences in their β-coefficients, variances, and covariance were used to estimate the β-coefficient ±SE for the substitution effect, and the HRs and 95 % CIs were calculated from these parameters.
To test the robustness of our primary findings, we conducted a series of sensitivity analyses: (a) repeating the models with only dairy consumers; (b) using the dairy consumption at baseline to assess the predictive power of simple measure of the dairy consumption on T2D risk instead of cumulative average consumption; and (c) longitudinal analysis was conducted also to assess the associations between dairy consumption changes during the follow-up and T2D risk. The average dairy consumption changes were calculated as changes from baseline to follow-up divided by the number of years of follow-up. Subjects were categorized into four groups according to their dairy consumption changes: (a) constant, <median (subjects with dairy consumption below median at baseline and follow-up); (b) increased consumption (subjects who increased their dairy consumption from below to above median during follow-up); (c) constant, ≥median (subjects with dairy consumption equal or above median at baseline and follow-up); and (d) decreased consumption (subjects who decreased their dairy consumption from equal or above to below median during follow-up); the group with constant low dairy consumption was considered the reference group.
Finally, effect modification by sex, BMI, and intervention group was examined also by including the interaction terms in univariate models. We examined linear trend by modeling the median values for dairy consumption categories as a continuous variable. All significance levels were calculated two-sided, and the significance level was set at P < .05. Analyses were performed with SPSS version 19.0.
Results
During a median follow-up of 4.1 (2.5-5.7) years, we documented 270 incident cases of T2D. The cumulative average consumption of total dairy in the study population was 363 g/d, with low-fat dairy products being the largest contributors (71 %). The main dairy products consumed were milk (63 %, of which 85 % was semi-skim/skim); yogurt (24 %, of which 70 % was skim); cheese (11 %); and processed dairy (4 %). The baseline characteristics of study population according to total dairy consumption tertile are shown in Table 1 . Those individuals with higher dairy product consumption were more likely to be older and women and have higher BMI and lower educational levels. And they were less likely to smoke, be physically active, and have lower plasma concentrations of fasting glucose and triglycerides and increased concentrations of total and HDL-cholesterol. Participants in the highest tertile of dairy also had a lower consumption of total energy and were more likely to have a healthier dietary pattern. Similar trends were observed for tertile of consumption of other dairy subgroups (low-fat, whole-fat dairy, total milk, and yogurt), except for the consumption of vegetable, fruit, and protein that were significantly lower in subjects with a high whole-fat dairy consumption than in subjects with a low consumption. Participants in the highest tertile of whole-fat dairy also had a higher consumption of total fat (Online Supplemental Table S1 and Table S2 ).
The HRs of T2D incidence according to dairy products consumption tertiles are shown in Tables 2 and 3 . Total and low-fat dairy consumption was associated with a reduced risk of T2D incidence after adjustment for various confounders (model 1 and model 2; P-trend < .05). Adjustment for other major food groups (model 3) did not materially alter the associations, and the corresponding HRs (95 % CIs) for the highest versus the lowest tertile of total and low-fat dairy consumptions were 0.68 (0.47-0.98) and 0.65 (0.45-0.94), respectively ( Table 2) .
Both total and low-fat milk consumption [HRs (95 % CI) 0.64 (0.45-0.89) and 0.53 (0.37-0.75); P-trend <.05, respectively] were inversely associated with T2D risk (model 2), but only low-fat milk consumption remained significantly associated with lower T2D risk after adjustment for additional confounders (Table 3) . Similarly, subjects with higher total yogurt consumption exhibited a 40 % lower risk of T2D (P-trend = .002). Furthermore, this risk reduction of T2D was maintained in both low-fat yogurt [HR 0.68 (95 % CI 0.47-0.97); P-trend < .047] and wholefat yogurt [HR 0.66 (95 % CI 0.47-0.92); P-trend < .020], when they were examined separately. We also analyzed total yogurt and low-fat milk consumptions as continuous variables; in model 2, an average increment of one serving/ day of the standard serving of yogurt (125 g) and low-fat Current smoker, n (%) 250 (22) 154 (13) 140 (12) Former smoker, n (%) 341 (29) 244 (22) 169 (14) Education level, n (%) <.001
Primary education 789 (68) 895 (77) 932 (81) Secondary education 231 (20) 176 (15) 152 (13) Academic/graduate 131 (12) 81 (7) 67 (6) Leisure time physical activity, (MET-min/day) 253.9 ± 232.6 222. (Table 3) . No significant association was found for whole-fat dairy products, total and whole-fat milk, cheese, concentrated full fat dairy, and processed dairy products. When we repeated all our analyses including only dairy consumers, the consumption of total and low-fat dairy and total yogurt was associated with a lower risk of T2D. Similarly, after full adjustment for potential confounders (model 3), total, low-fat dairy, and subtypes dairy (low-fat milk and total yogurt) were inversely associated with T2D when baseline dairy consumption instead of cumulative average consumption was used as the exposure variable. For the associations between dairy consumption changes during follow-up and T2D risk, results were not substantially different. Compared with subjects who consistently consumed below the median (reference group), subjects who increased their consumption of total, low-fat dairy, and total yogurt and yogurt subtypes (low-fat and whole-fat yogurt) during the follow-up period had a lower risk of developing incident T2D in the fully adjusted model (model 3) (Online Supplemental Table S3 ).
We also have considered the possible effect of dairy consumption on BMI over time, but further adjustment of the models for BMI changes during follow-up did not affect the results (data not shown). Furthermore, we found no interaction between total dairy or main dairy subtypes (milk, yogurt, and cheese) and sex, BMI, or intervention group.
Lower risks of T2D were also shown when one serving/ day of a combination of biscuits and chocolate confectionary (50 g) and whole grain biscuits and homemade pastries (50 g) was replaced with one serving/day of yogurt (125 g), and the corresponding HRs (95 % CIs) were 0.60 (0.38-0.94), and 0.55 (0.32-0.96), respectively (Table 4) .
Discussion
In this prospective study conducted on communitydwelling elderly subjects at high cardiovascular risk, we observed that a high consumption of dairy products was associated with decreased risk of T2D. The consumption of low-fat dairy products, mainly low-fat milk and both lowfat and whole-fat yogurt, was the main contributors to this association. Replacing biscuits and chocolate confectionary, or whole grain biscuits and homemade pastries, typical deserts or snacks in Spain, for yogurt was associated with a significantly lower risk of T2D. These findings highlight the potential role of dairy products in the prevention of T2D in older adults. Our results are supported by a recent meta-analysis of prospective studies conducted in apparently healthy individual showing a relative risk reduction of T2D in subjects who had a high compared to a low consumption of dairy [10] . Similarly, a recent evidence-based review [30] and three previous meta-analyses [8, 9, 11] using similar cohort studies also support the hypothesis that dairy consumption is associated with a reduced risk of T2D, and that, this association is dose-dependent. However, it is noteworthy that our population was elderly and had several cardiovascular risk factors. It is not known whether the associations that have been reported in apparently healthy individuals also occur in this population group, highly predisposed to develop T2D.
In terms of milk consumption, we found that only lowfat milk consumption was significantly inversely associated with T2D when we assessed both baseline and cumulative average consumption. Surprisingly, we found no Table 4 HRs (95 % CI) for type 2 diabetes of the substitution of one serving per day of alternative foods for one serving per day of yogurt and low-fat milk in the PREDIMED cohort
The servings are based on energy-adjusted cumulative average food consumption. Values are given as HR (95 % CI) from Cox regression models adjusted for age, sex, BMI, dietary intervention group (MedDiet supplemented with virgin olive oil, and/or nuts, or control group), leisure time physical activity (MET-min/day), educational level (primary education, secondary education, or academic/graduate), smoking (never, former, or current smoker), hypertension, or antihypertensive use (yes/no), and fasting glucose, HDL-cholesterol, and triglyceride concentrations. associations between low-fat milk consumption changes during the follow-up and T2D risk. Therefore, these findings should be taken with caution. The apparent discrepancy between our findings might be explained by a high consumption of low-fat milk at baseline (median consumption 198 g/day), making it difficult to find an additional protective effect against T2D with an increment of their consumption during follow-up period. For milk consumption, previous findings are inconsistent: They show inverse associations with total and low-fat milk [12, 19, 31] , positive associations with whole-fat milk [12, 17] , or no association with total, low-fat [12, 18, 21-24, 27, 28] , or whole-fat milk [13, 20] . In our cohort, the major dairy sources were low-fat dairy products, which were consumed more frequently than whole-fat dairy food. Overall, milk was the largest contributor to total dairy product consumption, and more than two-thirds of milk consumption was from low-fat milk. The amount and type of fat contained in these dairy products could mitigate their potential benefits on T2D, thus explaining the null relationship found in the present study in whole-fat dairy. However, in the present study, the nonsignificant association observed between whole-fat dairy consumption and T2D could be due to the lack of power to detect associations, because of the low consumption of these dairy products. In addition, observational evidence does not support the hypothesis that dairy fat or whole-fat dairy foods may contribute to T2D risk. A recent systematic review of observational studies on the consumption of regular/high-fat dairy products suggests no association with or beneficial impact on T2D [32] . Thus, it is difficult, then, to draw any conclusions about whether the consumption of whole-fat or low-fat dairy products can be more beneficial.
Regarding other dairy subtypes, many observational studies, but not all [23, 26] , suggest that a high consumption of fermented dairy products tends to be associated with lower T2D risk, either significantly [12, 13, 16, 27, 28] or nonsignificantly [19, 21, 22, 24] . As in other large prospective studies [12, 13, 16, 28, 33] , in our study, individuals in the top tertile of total yogurt consumption had a 40 % lower risk of T2D than those in the reference tertile. A nonsignificant positive association between cheese consumption (including all types of cheese) and T2D risk was demonstrated in the present study. In agreement with our results, after a 5-year follow-up, in the recent prospective EPICNorfolk study [28] , individuals in the top tertile of yogurt consumption had a 28 % lower risk of T2D than those in the reference tertile. In the same cohort, an increased lowfat fermented dairy consumption (all yogurt and low-fat unripened cheeses) was associated with a 24 % reduction in the risk of T2D, whereas total fermented dairy and cheese showed no associations [28] . Interestingly, in another large prospective study, the EPIC-InterAct study [27] , a reduction in the T2D risk was only observed in individuals in the highest versus the lowest quintile of consumption of total fermented dairy products and cheeses. Although there was a trend toward lower risk, the authors did not find a significant association with total yogurt consumption. In a recent analysis of three large cohort studies, a high consumption of yogurt was also associated with a reduced risk of T2D, whereas other dairy foods and consumption of total dairy were not appreciably associated with incidence of T2D [33] . In contrast, other studies do not support a protective role for fermented dairy consumption and T2D risk [23, 24] . In our study, we also found that the consumption of combined fermented dairy products (all yogurt and types of cheese) had a nonsignificant protective association with T2D, which was significant for subjects in the second tertile compared to the reference tertile. Regarding cheese consumption, unlike our results, previous prospective studies suggested a trend but not a statistically significant inverse association with T2D [12, 13, 19, [21] [22] [23] [24] . Differences in the design, population studied, dietary assessment tools used, disparities in the combination of different types of cheese, and/or the inability to distinguish between them may explain the conflicting results. Thus, future intervention studies are warranted to demonstrate whether consumption of cheese or fermented dairy has any beneficial effect on T2D.
In our study, both yogurt and low-fat milk consumption were strongly associated with a lower risk of T2D. However, only yogurt consumption was associated with a reduction in risk when one serving of a combination of biscuits and chocolate confectionary or whole grain biscuits and homemade pastries was replaced with one serving of yogurt. The reason for the reduction in the risk of T2D associated with yogurt but not with milk consumption remains unclear. Although nutritionally yogurt is comparable to milk, processing, added ingredients, and fermentation improve the nutritional value of yogurt and provide it with unique properties that enhance the bioavailability of some nutrients (e.g., riboflavin, vitamin B 12 , calcium, magnesium, zinc) [34, 35] . Therefore, yogurt consumption may help to ameliorate some of the most common nutritional deficits and related complications in older adults.
Multiple mechanisms might mediate the relationship between dairy consumption and T2D risk.
Such components of dairy products as calcium, magnesium, potassium, and vitamin-D have been attributed with having a potential benefit on T2D [36] [37] [38] . However, most studies have found that the inverse association between dairy consumption and T2D persisted after adjustment for these micronutrients, suggesting that it is unlikely that these micronutrients mediate such associations. Other postulated mechanisms include the satiating effect of some dairy proteins and fats, which may help in maintaining a lower energy intake and decreasing weight and obesity risk [32] , an important mediator in T2D development [12, 13, 16] . However, the observed associations were not substantially changed when we made further adjustments for BMI changes during follow-up. We also found no significant interaction between BMI and dairy on T2D risk. Therefore, it is unlikely that the BMI might be responsible for the beneficial effect observed in our study. Participants of the PREDIMED trial are at high cardiovascular risk, only very few of them had a normal weight (<10 %), and therefore, our statistical power to perform subgroup analyses regarding overweight status is insufficient.
Another potential mechanism is that some dairy proteins are also known to be insulinotropic [39] , contributing to the reduction in T2D risk. However, this is merely a speculation, and further research investigating the effects of dairy proteins in particular on the glycemic response and T2D risk is required. Furthermore, it should be taken into account that the beneficial metabolic effects on health of fermented dairy, and particularly yogurt, could be explained by the live microorganisms they contain (probiotic bacteria) [35, 40] . Thus, it is plausible that bioactive components present in dairy products may act synergistically or antagonistically to produce a holistic beneficial effect on T2D, such as was observed in our study.
In addition to the direct effects of dairy products, we cannot ignore displacement effects [34] , as individuals who consumed higher amounts of dairy also consumed higher amounts of other foods, such as fruit, legumes, and lower amounts of total meat, fish, nuts, and alcohol, which might also have an impact on associations observed. However, the apparently protective relationship of dairy persisted in multivariate models that accounted for dietary variables. On the other hand, it has also been reported that a dairy-rich diet produces significant and substantial suppression of the oxidative and inflammatory stress associated with overweight and obesity [41] and thus with reduced T2D risk.
The present study has strengths that distinguish it from previous studies. The incidence of T2D was not selfreported and was verified by a second analytical test, thus making the identification of new incident cases more reliable. In addition, cases were ascertained and confirmed by an independent Clinical Event Adjudication committee. Other strengths of our study include the use of yearly repeated measurements of diet, a relatively long follow-up period, control for many potential confounding factors, and a relatively high consumption of low-fat dairy products and yogurt, which allows a better assessment of the associations between dairy consumption and T2D.
However, some limitations should also be noted. First, the generalizability of our results to other populations may be limited because participants were elderly Mediterranean individuals at high cardiovascular risk. Second, although diet was assessed by a validated FFQ, measurement errors are inevitable. However, to minimize the random measurement error caused by within person variation and dietary changes during the follow-up, we calculated the cumulative average for dietary variables to better represent a longterm habitual dietary consumption. A third limitation of our study is that the low consumption of whole-fat dairy products, such as whole-fat milk and cheese, might limit the ability to detect possible associations.
In conclusion, this study suggests that a high consumption of dairy products, and particularly yogurt, may be protective against T2D in elderly individuals at high cardiovascular risk highly predisposed to develop this condition.
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